Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (151-160 of 205) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironmentNadja I Lorenz, Benedikt Sauer, Hans Urban, et al.
Brain Pathology (Zurich, Switzerland)|November 27, 2023
DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classificationKai Schmid, Jannik Sehring, Attila Németh, et al.
Oncotarget|October 31, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastasesPatrick N Harter, Simon Bernatz, Alexander Scholz, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2026
The prognostic significance of TSPO-PET imaging in IDH-mutant glioma: a single-center, retrospective studyKatharina J Müller, Roman Stürzl, Sabrina Kirchleitner, et al.
Acta Neuropathologica|March 27, 2023
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genesLucas Hoffmann, Roland Coras, Katja Kobow, et al.
Nature Cancer|February 5, 2022
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasisFlorian Klemm, Aylin Möckl, Anna Salamero-Boix, et al.
Acta Neuropathologica|June 25, 2022
Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic strokeDaniel Spitzer, Sylvaine Guérit, Tim Puetz, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasisJens Blobner, Laura Dengler, Constantin Eberle, et al.
Pageof 21

Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironmentNadja I Lorenz, Benedikt Sauer, Hans Urban, et al.
Brain Pathology (Zurich, Switzerland)|November 27, 2023
DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classificationKai Schmid, Jannik Sehring, Attila Németh, et al.
Oncotarget|October 31, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastasesPatrick N Harter, Simon Bernatz, Alexander Scholz, et al.
Acta Neuropathologica|April 9, 2018
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrenceLeah M Katz, Thomas Hielscher, Benjamin Liechty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2026
The prognostic significance of TSPO-PET imaging in IDH-mutant glioma: a single-center, retrospective studyKatharina J Müller, Roman Stürzl, Sabrina Kirchleitner, et al.
Acta Neuropathologica|March 27, 2023
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genesLucas Hoffmann, Roland Coras, Katja Kobow, et al.
Nature Cancer|February 5, 2022
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasisFlorian Klemm, Aylin Möckl, Anna Salamero-Boix, et al.
Acta Neuropathologica|June 25, 2022
Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic strokeDaniel Spitzer, Sylvaine Guérit, Tim Puetz, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasisJens Blobner, Laura Dengler, Constantin Eberle, et al.
Pageof 21